Literature DB >> 8951917

Pain and its persistence in herpes zoster.

R H Dworkin1, R K Portenoy.   

Abstract

The nature and duration of pain associated with herpes zoster is highly variable. This review of research on pain in acute herpes zoster and postherpetic neuralgia (PHN) explores those observations relevant to the definition and pathogenesis of PHN and the design of treatment trials. A model for the pathogenesis of PHN is presented, which gains support from studies of risk factors. Several directions for future research are identified.

Entities:  

Mesh：

Year:  1996        PMID： 8951917     DOI： 10.1016/0304-3959(96)03122-3

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


  64 in total

1.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

2.  Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland.

Authors:  Thomas D Szucs; Reto W Kressig; Manto Papageorgiou; Werner Kempf; Jean-Pierre Michel; Anton Fendl; Xavier Bresse
Journal:  Hum Vaccin       Date:  2011-07-01

Review 3.  The management of postherpetic neuralgia.

Authors:  D Bowsher
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

4.  Cervical dermatomal zona misdiagnosed as ulnar nerve entrapment.

Authors:  Celal Şalçini; Gülin Sunter; Seyit Ali Gumustas; Alper Evrensel
Journal:  BMJ Case Rep       Date:  2015-06-01

5.  Cost-effectiveness of a herpes zoster vaccination program among the French elderly people.

Authors:  Emmanuel Belchior; Daniel Lévy-Bruhl; Yann Le Strat; Magid Herida
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

6.  Natural history of pain following herpes zoster.

Authors:  Hans Gustav Thyregod; Michael C Rowbotham; Michelle Peters; Jessica Possehn; Marlene Berro; Karin Lottrup Petersen
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

7.  Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.

Authors:  Hiltrud Liedgens; Nadine Hertel; Anja Gabriel; Mark Nuijten; Helen Dakin; Stephen Mitchell; Barbara Poulsen Nautrup
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

8.  Cost effectiveness of herpes zoster vaccine in Canada.

Authors:  Mehdi Najafzadeh; Carlo A Marra; Eleni Galanis; David M Patrick
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 9.  [Varicella-zoster virus infections].

Authors:  H M Lilie; S W Wassilew
Journal:  Hautarzt       Date:  2004-09       Impact factor: 0.751

10.  Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Authors:  Adriana Weinberg; Jane H Zhang; Michael N Oxman; Gary R Johnson; Anthony R Hayward; Michael J Caulfield; Michael R Irwin; James Clair; Jeffrey G Smith; Harold Stanley; Rocio D Marchese; Ruth Harbecke; Heather M Williams; Ivan S F Chan; Robert D Arbeit; Anne A Gershon; Florian Schödel; Vicki A Morrison; Carol A Kauffman; Steve E Straus; Kenneth E Schmader; Larry E Davis; Myron J Levin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.